Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: functioning and resource use

dc.contributor.author	García-Portilla González, María Paz
dc.contributor.author	Llorca, P. M.
dc.contributor.author	Maina, G.
dc.contributor.author	Bozikas, V. P.
dc.contributor.author	Devrimci Ozguven, H.
dc.contributor.author	Kim, S. W.
dc.contributor.author	Bergmans, P.
dc.contributor.author	Usankova, I.
dc.contributor.author	Cherubin, P.
dc.contributor.author	Pungor, K.
dc.date.accessioned	2019-08-21T07:33:19Z
dc.date.available	2019-08-21T07:33:19Z
dc.date.issued	2019
dc.identifier.issn	0924-977X
dc.identifier.issn	1873-7862
dc.identifier.uri	http://hdl.handle.net/10651/51899
dc.description	European College of Neuropsychopharmacology, ECNP Congress (31st, 2018, Barcelona, Spain)
dc.format.extent	p. S238-S239
dc.language.iso	eng
dc.relation.ispartof	European Neuropsychopharmacology, 29(S1)
dc.rights	© 2018 Published by Elsevier B.V.
dc.source	WOS:000458400500326
dc.title	Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: functioning and resource use
dc.type	conference output	spa
dc.identifier.doi	10.1016/j.euroneuro.2018.11.383
dc.relation.publisherversion	http://dx.doi.org/10.1016/j.euroneuro.2018.11.383

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.